A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab
- PMID: 35959513
- PMCID: PMC9788173
- DOI: 10.1111/dth.15766
A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab
Conflict of interest statement
Matteo Megna acted as a speaker or consultant for Abbvie, Eli Lilly, Janssen, Leo‐Pharma, and Novartis. G. Fabbrocini acted as a speaker or consultant for Abbvie, Amgen, Eli Lilly, Janssen, Leo‐Pharma, Almyrall, Novartis, and UCB. The remaining authors declare no conflict of interest.
Figures
References
-
- Ocampo DV, Gladman D. Psoriatic arthritis. F1000Res. 2019;8:19144 F1000 Faculty Rev‐1665.
-
- Salaffi F, Di Carlo M, Luchetti MM, et al. A validation study of the simple psoriatic arthritis screening (SiPAS) questionnaire to screen psoriasis patients for psoriatic arthritis. Clin Exp Rheumatol. 2018;36(1):1074‐1081. - PubMed
-
- Messina F, Valenti M, Malagoli P, et al. Early predictors of psoriatic arthritis: a delphi based consensus from Italian dermatology centers. Ital J Dermatol Venerol. 2022;157:231‐234. - PubMed
-
- Megna M, Balato A, Raimondo A, Balato N. Guselkumab for the treatment of psoriasis. Expert Opin Biol Ther. 2018;18(4):459‐468. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
